Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Xiaojia Wang, PHD
CONTACT
Jian Huang, chief doctor
CONTACT
Lead
Zhejiang Cancer Hospital
With
A multi-center, randomized, open-label study on pharmacokinetics, safety, efficacy, and immunogenicity of Cipterbin combined with Vinorelbine Injection every week or every three weeks in the treatment of patients with HER2-positive metastatic breast cancer. The main purpose was to compare pharmacokinetics Index between two groups, secondly to observe safety, efficacy, and immunogenicity
Age
18–70
Sex
FEMALE
Healthy volunteers
Not accepted